Withings Body Scan 2 scale can detect health risk factors such as hypertension at home

At CES 2026, Withings is announcing its new Body Scan 2 scale, which the company claims is the first at-home scale able to detect certain heart conditions, including your risk for hypertension.

The Withings Body Scan 2 scale uses a combination of a standard floor scale with a retractable handle to track over 60 different biomarkers, all in about 90 seconds. Some of these are brand new to Body Scan 2, and Withings says that a select few are “world’s first” in an at-home scale.

One of these is support for a hypertension risk notification. Without the use of a cuff, the Body Scan 2 uses a special AI model to detect arterial hypertension risk, helping to address a major risk factor for a stroke. Another first-time feature is the ability to catch potential glycemic dysregulation, which can help provide an early warning for things such as prediabetes. Support for Impedance Cardiography (ICG) is also available for the first time on an at-home scale here, with the data captured able to help detect how your heart is pumping blood and any factors that might be affecting that.

Withings says that many of these biomarker detection features are clinically validated and are designed to help users make lifestyle changes to address factors that many of us simply don’t think about.

Advertisement - scroll for more content

Body Scan 2 will also provide a “Health Trajectory score” to help offer a view of how said changes can improve your long-term health.

Like other connected scales from Withings, Body Scan 2 can connect to other apps such as Fitbit through Android Health Connect. Withings says that the scale can last up to 15 months and syncs via Wi-Fi or Bluetooth.

Withings Body Scan 2 will be available in Q2 2026, but it won’t be cheap. In the US, it will be sold for $599, a $100 increase over the prior generation.

Follow Ben: Twitter/X, Threads, Bluesky, and Instagram